ISHLT Extracorporeal Photopheresis Immunomodulation in Thoracic Transplantation Challenge Grant
Forecasted
Supports early career research on extracorporeal photopheresis to improve outcomes and prevent rejection in heart and lung transplant patients.
Funder: International Society for Heart and Lung Transplantation
Due Dates (Anticipated): December 2026 (ISHLT membership application submitted by; applicant must be an active member or have submitted a completed membership application by this date)
Funding Amounts: One award of up to $90,000 for a one-year research project.
Summary: Supports early career research advancing extracorporeal photopheresis immunomodulation to improve outcomes in cardiothoracic transplant patients.
Key Information: Finalists must present at the ISHLT Annual Meeting; ISHLT membership required at application.
Description
This grant aims to advance the use of extracorporeal photopheresis (ECP) immunomodulation to improve survival, health-related quality of life, and organ function in cardiothoracic transplant patients. It encourages research on early use of ECP, prevention of chronic rejection, identification of biomarkers of treatment response, and application in high-risk, frail patients with comorbidities. The grant is specifically intended for early career investigators and seeks projects with the potential to significantly impact clinical practice in heart and lung transplantation.
